Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized cross-over comparison of K-LA5 vs Kindaly AF-4 in hemodialysis
jRCT2080223878Phase 3Completed
- Sponsor
- Fuso Pharmaceutical Industries
- Start
- Apr 2018
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic kidney disease (CKD) and end-stage kidney disease (ESKD) (2 arms), sponsored by Fuso Pharmaceutical Industries. Primary endpoint: Elimination of azotemia-related substances. Started Apr 2018; status: completed.
02
Conditions
chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on jRCT2080223878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223878.